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Rationale.The sleep-related factors that modulate the nocturnal worsening of asthma in children are poorly understood.This study
addressed the hypothesis that asthmatic children have a REM sleep-related vulnerability trait that is independent of OSA.Methods.
We conducted a retrospective cross-sectional analysis of pulse-oximetry signals obtained during REM and NREM sleep in control
and asthmatic children (𝑛 = 134). Asthma classification was based on preestablished clinical criteria. Multivariate linear regression
model was built to control for potential confounders (significance level 𝑃 ≤ 0.05). Results. Our data demonstrated that (1) baseline
nocturnal respiratory parameters were not significantly different in asthmatic versus control children, (2) the maximal % of SaO
2
desaturation during REM, but not during NREM, was significantly higher in asthmatic children, and (3) multivariate analysis
revealed that the association between asthma and REM-related maximal % SaO
2
desaturation was independent of demographic
variables. Conclusion. These results demonstrate that children with asthma have a REM-related vulnerability trait that impacts
oxygenation independently of OSA. Further research is needed to delineate the REM sleep neurobiological mechanisms that
modulate the phenotypical expression of nocturnal asthma in children.
1. Introduction
Asthma is a chronic inflammatory disease characterized by
worsening of symptoms during sleep [1, 2]. This nocturnal
vulnerability of asthmatic individuals has been previously
attributed to increased vagal tone, decreased sympathetic
activity, reduced functional residual capacity of the lungs
(affecting the small airways), endogenous circadian system
changes during the night, and a higher risk for obstruc-
tive sleep apnea (OSA) in the asthmatic population [2–4].
Interestingly, several studies have reported that asthmatic
patients deteriorate more during the morning hours with the
majority of respiratory arrests and sudden deaths occurring
frommidnight to 8 am [5, 6].The latter phenomenon suggests
a greater influence of the rapid eye movement (REM) sleep in
the asthmatic condition since this sleep stage predominates
during the second part of the night [7].
REM sleep is considered particularly important in the
pathogenesis of OSA and other sleep-related breathing
abnormalities [8–12]. It has also been suggested that REM
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sleep is characterized by nocturnal bronchoconstriction [13].
In the context of pediatric asthma, we have recently identified
that asthmatic children with OSA have more REM sleep-
related breathing abnormalities relative to children with OSA
alone [14]. These findings suggested that asthmatic patients
have a REM sleep vulnerability trait that predisposes them to
have more respiratory abnormalities during this sleep stage.
In support of this notion, Catterall et al. have previously
demonstrated that stable adult asthmatics have irregular
breathing and hypoxemia clustered during REM sleep [15].
Importantly, OSA worsens during REM sleep as well [8–12],
thus REM-related breathing abnormalities in asthmatic indi-
viduals may be just a reflection of the well-known association
between asthma andOSA [4]. Accordingly, to better delineate
the link between asthma and REM sleep in children, our cur-
rent study investigatedwhether asthmatic children havemore
REM sleep-related hypoxemia independently of the presence
of OSA. To this end, we conducted stage specific (REMversus
NREM sleep) signal processing of the pulse-oximetry chan-
nel recorded during overnight polysomnography (PSG) in
asthmatic children without OSA as previously described [14].
Our main hypothesis was that asthmatic children without
OSA would have more REM-related hypoxemia, expressed
as the maximal percentage of SaO
2
desaturation during REM
sleep, relative to control children without asthma. Secondary
analysis evaluated the influence of modulatory factors of
REM-related breathing abnormalities, such as gender, age,
and ethnicity [16], in the association between REM-related
hypoxemia and asthma in children.
2. Materials and Methods
2.1. Subjects. A database of all children that underwent rou-
tine overnight polysomnogram (PSG) at the Penn State Sleep
Research and Treatment Center (SRTC) between January
2010 and June 2011 was reviewed. Patients were eligible for the
study if their PSG ruled out the diagnosis of obstructive sleep
apnea (OSA). Almost all patients were referred to PSG to rule
outOSA.OSAwas defined as an obstructive apnea-hypopnea
index (OAHI)≥ 1.5 events per hour [17–20].Only the patient’s
initial PSG was included in the study. Infants, school age
children, and young adolescents were included (2–13 years).
Patients were excluded if they had need for supplemental
oxygen or positive airway pressure, central hypoventilation
syndromes, congenital heart disease, severe developmental
delay, cerebral palsy, genetic syndromes, craniofacial abnor-
malities, or neuromuscular disorders. Patients without com-
plete clinical and PSG data available were also excluded from
the study. Asthma status was determined based on electronic
medical records reviewed in Penn State Children’s Hospital
and Penn State SRTC. This study was approved by the
Institutional ReviewBoard of Penn State College ofMedicine.
2.2. PSG Protocol, Scoring, and Analysis. Standard pediatric
overnight PSG was performed on all patients. During 9-
10 hours, the child’s sleep was continuously recorded to
a computerized system (Twin PSG software; Grass Technolo-
gies. Inc., West Warwick, RI, USA) and scored manually
in 30-second epochs according to the American Academy
of Sleep Medicine (AASM) standardized criteria [17]. PSG
measurements included electroencephalograms (EEG), elec-
trooculograms (EOG), electrocardiogram (ECG), mental-
submental electromyogram (EMG), thoracic and abdominal
wallmotion (respiratory inductance plethysmography), pulse
oximetry (with 2 s averaging time), end-tidal carbon dioxide
monitoring, combined nasal/oral thermistor, and nasal pres-
sure. Sleep stages and respiratory events were scored accord-
ing to the AASM pediatric scoring criteria [17]. Five AASM
sleep stageswere identified (wake stage =W, stage 1 =N1, stage
2 = N2, stage 3 = N3, and stage REM = R). For the purpose
of this investigation, we used OAHI and respiratory data
calculated for W stage (beginning of PSG), non-REM stage
(represented by N1, N2, and N3), and REM sleep. The OAHI
was calculated separately during REM, NREM sleep, and
total sleep time (TST). Pulse-oximetry signal was examined
separately and carefully cleaned from artifacts. “Maximal
percentage of SaO
2
desaturation” was calculated with the
formula (SaO
2
baseline − SaO
2
nadir)/SaO
2
baseline, and
it was individually measured during NREM and REM sleep
stages as previously described [14]. Additional respiratory
analyses were conducted to obtain baseline SaO
2
during TST,
wake, NREM, and REM sleep.
2.3. Asthma Status and Other Covariables. Clinical and
demographic variables were obtained reviewing electronic
medical records in Penn State Children’s Hospital and Penn
State Sleep Research and Treatment Center. “Asthma” was
defined in this pediatric population using a definition that
required the presence of at least one of the following cri-
teria: (1) ever being diagnosed with asthma by a physician
on the basis of criteria recommended for children 0–4
and 5–11 years of age in the National Institute Of Health
(NIH) National Asthma Education and Prevention Program
(NAEPP) Guidelines [1] and (2) use of asthma therapy and/or
presence of asthma symptoms in the past 12 months. Other
covariables investigated included age, race, sex, body mass
index (BMI), percent of REM sleep, total sleep time (TST),
and TST in supine position.
2.4. Statistical Analysis. Data were analyzed using the soft-
ware SAS version 9.3 or later (SAS Institute Inc., Cary, NC,
USA). Exploratory data analysis on main variables were
performed for the entire study population and stratified
according to asthma status. SaO
2
parameters were calcu-
lated separately for REM and NREM sleep. For pair-wise
relationships, two-sample 𝑡-test was used to compare the
mean value of the continuous outcome measures such as
SaO
2
-derived measurements, and chi-square test was used
to compare the proportion of positive signals for binary
outcomes. Multivariate linear regression model was built to
study the joint effect of asthma and maximal percentage
of SaO
2
desaturation during REM with control of possible
confounders such as gender, age, and ethnicity. Significance
was taken at the 𝑃 < 0.05 level.
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3. Results
3.1. Study Population. 134 children and young adolescents (2–
13 years) were included in this study. The total study popula-
tion was subdivided into one group with asthma (𝑛 = 46)
and another group without the disease (𝑛 = 88). Comparison
of demographic, anthropometric, and baseline PSG variables
between these two groups revealed no significant differences
(Tables 1 and 2).
3.2. Children with Asthma Are Susceptible to Nocturnal
Hypoxemia during REM Sleep. We first examined pulse-
oximetry signals at baseline and during sleep stages (REM
versus NREM) in children with asthma and contrasted them
with those seen in children without this condition (control).
As shown in Table 2, the mean SaO
2
parameters obtained
during wake, REM, and NREM sleep were not significantly
different in asthmatic children compared to those in the
control group (Table 2). In the same way, the maximal per-
centage of SaO
2
duringREMandNREMwas not significantly
different in those children without asthma (REM 4.4% ± SD
2.4 versus NREM 4.2% ± SD 2.5, 𝑃 = 0.38) (Figure 1). The
mean SaO
2
nadir in the asthma group was slightly lower
(93.49 ± SD 2.2) relative to the control group (94.14 ± SD 1.5),
but this difference did not reach statistically significance (𝑃 =
0.08) probably because this nadir included REM and NREM
sleep values. In contrast, children with asthma had amaximal
percentage of SaO
2
desaturation that was significantly higher
during REM relative to that seen in NREM (REM 6.2% ± SD
2.9 versus NREM 4.4 ± SD 2.0, 𝑃 = 0.001).
3.3. The Association between Asthma and REM-Related Hyp-
oxemia Is Independent of Gender, Age, and Ethnicity. REM-
related breathing abnormalities have been linked to younger
age and female gender [16]. Accordingly, we built a mul-
tivariate linear regression model to assess the confounder
effect of age, gender, and ethnicity in the relationship between
asthma andmaximal percentage of SaO
2
desaturation during
REM sleep (Table 3). After adjusting for these covariables, we
found that the effect of asthma in REM-related hypoxemia
(maximal % REM SaO
2
desaturation) is independent of age,
gender, and ethnicity (adjusted 𝑃 = 0.04, Table 3).
4. Discussion
The most important finding of the current study is that
the maximal percentage of SaO
2
desaturation during REM,
but not during NREM, is significantly greater in asthmatic
children without OSA. Accordingly, our data suggest that
children with asthma have a REM-related vulnerability trait
that impacts oxygenation independently of OSA according to
PSG criteria.
There is clear evidence supporting the worsening of
asthma during sleep. The largest study of the prevalence
of nocturnal asthma symptoms was reported by Turner-
Warwick [21]. This survey of 7729 patients with asthma
revealed that 74% awoke at least once per week with asthma
symptoms [21]. Several asthma studies have also shown
decreased pulmonary function and increased inflammatory
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Figure 1: Maximal SaO
2
desaturation in REM and NREM sleep
by asthma status in children. Data are presented as mean and
95% confidence interval (CI). REM: rapid eye movement; NREM:
nonrapid eye movement; SaO
2
: Oxygen saturation; 𝑃 values are
obtained by two-sample student 𝑡-test.
markers at nighttime. Kelly et al. [22] demonstrated that
the forced expiratory volume in the first second (FEV1) of
patients with asthma is significantly worse at 4:00 A.M.
compared to 4 P.M. [22]. Bonnet et al. performed inhalation
challenges every 4 h for 13 consecutive times in asthmatic
patients and found 24 hour oscillations in the pulmonary
sensitivity to histamine and methacholine, with at least
doubling concentrations required for the same effect at
certain times of day [23]. Additionally, Kraft et al. [24]
reported that patients with nocturnal asthma exhibit higher
concentrations of inflammatory markers in the distal airways
(leukocyte, neutrophil, and eosinophil counts) at nighttime
[24]. Collectively, these data support the prevailing notion
that the asthmatic condition is highly influenced by the
nocturnal phase of circadian rhythms.
In concert with circadian changes at night, specific sleep
stages appear to modulate the phenotypical expression of
asthma. Shapiro et al. reported that nocturnal bronchocon-
striction may be associated with REM sleep [13]. Catterall et
al. also identified that individuals with chronic stable asthma
have irregular breathing and greater fluctuations in SaO
2
during REM sleep relative to controls [15]. In children, we
have recently reported that asthmatic subjects with OSA
have clustering of obstructive events and hypoxemia during
REM sleep compared to children with OSA alone [14].
Based on these observations, our current study postulated
that asthmatic children without OSA also have nocturnal
respiratory abnormalities during REM sleep. To test this
hypothesis, we conducted signal processing of the pulse-
oximetry channel used during PSG to calculate stage specific
(REM versus NREM) means and maximal SaO
2
desatura-
tions as previously described [14]. Our data demonstrated
that children with asthma have greater REM-relatedmaximal
SaO
2
desaturation relative to those children without asthma.
There are several neurobiological mechanisms that might
underlie the potential modulatory role of REM in asthma.
REM sleep is characterized by increased cholinergic outflow
and ablated noradrenergic signals in the brainstem [25–27],
which are in turn critical modulators of the caliber and
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Table 1: Demographic profile of subjects.
Factors/variables Total (𝑛 = 134) Control (𝑛 = 88, 66%) Asthma (𝑛 = 46, 34%) 𝑃 value
Demographic variables
Gender 0.28
Female 58 (43%) 41 (46%) 17 (37%)
Male 76 (57%) 47 (54%) 29 (63%)
Age: mean (SD) 6.32 (2.9) 6.1 (2.9) 6.8 (2.9) 0.18
Ethnicity 0.95
White 96 (62%) 55 (67%) 41 (65%)
Others 49 (37%) 27 (33%) 22 (35%)
BMI: mean (SD) 18.5 (5.3) 17.8 (4.3) 19.6 (5.9) 0.08
For quantitative variables, data are presented as mean ± standard deviation (SD). BMI: body mass index; for categorical variables, data are presented as count
number (column percentage). 𝑃 values are obtained by either two-sample 𝑡-test or chi-square test, depending on the type of variables.
Table 2: Polysomnographic parameters of subjects.
Factors/variables Control(𝑛 = 88, 66%)
Asthma
(𝑛 = 46, 34%) 𝑃 value
Sleep study parameters
OAHI
Events/hr; mean (SD) 0.35 (0.4) 0.39 (0.4) 0.65
Total sleep time (TST)
Min; mean (SD) 535 (61) 526 (41) 0.28
TST supine %
Mean (SD) 43.3 (27.2) 46.3 (22) 0.67
REM (%)
Mean (SD) 18.8 (5.1) 21.3 (4.9) 0.35
Max % REM SAO2
desaturation
Mean (SD) 4.4 (2.5) 6.2 (2.8) 0.001∗∗
Max % NREM SAO2
desaturation
Mean (SD) 4. 4 (2.5) 4.7 (2.0) 0.38
SAO2 (wake)
Mean (SD) 97.3 (1.4) 97.2 (0.9) 0.54
SAO2 (REM, average)
Mean (SD) 97 (1.0) 97 (1.2) 0.85
SAO2 (NREM, average)
Mean (SD) 96.8 (1.0) 96.6 (1.2) 0.28
For quantitative variables, data are presented as mean ± standard deviation
(SD). SAO2: saturation of oxygen; REM: rapid eye movement; OAHI:
obstructive apnea-hypopnea index. For categorical variables, data are pre-
sented as count number (column percentage).𝑃 values are obtained by either
two-sample 𝑡-test or chi-square test, depending on the type of variables.
Statistically significant results are shown in bold font.
reactivity of the lower airways in mice [25–27]. In addition,
animal models of allergic asthma have illustrated that allergic
lung inflammation may affect central noradrenergic control
of cholinergic outflow to the airways, thereby augmenting
bronchoconstrictive reflex responses in the asthmatic state
[28]. The tone of the accessory respiratory muscles is also
markedly decreased during REM sleep, which may reduce
pulmonary reserve and lead to hypoventilation-hypoxemia in
many respiratory conditions including asthma [29].The latter
Table 3: Multivariate regression analysis results for the association
between rhinitis and REM-OAHI adjusted by co-variables.
Multivariate regression analysis for max % REM SAO2
desaturation
Predictors Parameter estimate SE 𝑃-value
Asthma 1.26 0.62 0.04∗
Age yrs −0.08 0.10 0.41
Gender −0.90 0.59 0.13
Ethnicity −0.18 0.27 0.50
Data are presented as parameter estimate, standard error (SE). REM: rapid
eye movement; OAHI: obstructive apnea-hypopnea index. Adjusted 𝑃-
values are obtained by multiple linear regression.
Statistically significant results are shown in bold font.
information, together with our current findings, support the
notion that REM sleep neurobiology plays a key role in the
normal functioning of the lower airways and so it might
modulate the nocturnal manifestations of asthma children.
In evaluating the implications of the present observations,
it is important to mention that our investigation used a cross-
sectional designwith a retrospective cohort of children.Thus,
this study has the potential limitations of any retrospective
analysis such as selection bias andmisclassification of disease
(information bias) resulting from inaccurate documentation
in medical records. In terms of potential confounders, our
design and statistical analysis accounted for several important
covariables for the association between REM-related hypox-
emia and asthma. For instance, our study excluded children
with chronic lung disease, neuromuscular disorders, cerebral
palsy, craniofacial abnormalities, and dysmorphic genetic
syndromes, as they have a higher risk for nocturnal hypox-
emia. Nonetheless, snoring was not evaluated and was likely
present in a large number of children included in the study,
so they cannot be necessarily regarded as otherwise healthy
children with asthma. On the other hand, the strengths of
our study included the relatively large sample size and the use
of objective data to evaluate the influence of REM in asthma
(PSG scoring and sleep-stage signal processing).
In summary, we feel that enough evidence is presented to
support the concept that children with asthma have a REM-
related vulnerability trait that impacts oxygenation indepen-
dently of OSA. Further research is needed to delineate the
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biological link between REM-sleep and the physiology of the
lower airways during health and disease. New knowledge in
this area may allow the discovery of mechanistic pathways
that connect airway inflammation and function with sleep
biology, which in turn may result in novel strategies for the
treatment of nocturnal symptoms of asthma.
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